v3.26.1
FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Industries and Geographical Locations Comprising Greater than 10% of Portfolio Fair Value (Details) - USD ($)
 9 Months Ended 12 Months Ended
Mar. 31, 2026
Jun. 30, 2025
Concentration Risk [Line Items]    
Cost $ 69,812,379 [1] $ 88,404,806 [2]
Fair Value 63,037,631 [3] 85,016,596 [4]
Healthcare & Pharmaceuticals    
Concentration Risk [Line Items]    
Cost 24,174,301 22,729,225
Fair Value $ 25,379,006 $ 22,902,129
Healthcare & Pharmaceuticals | Investments at Fair Value | Industry Concentration Risk    
Concentration Risk [Line Items]    
% of Portfolio 40.00% 27.00%
All Other Industries    
Concentration Risk [Line Items]    
Cost $ 45,638,078 $ 65,675,581
Fair Value $ 37,658,625 $ 62,114,467
All Other Industries | Investments at Fair Value | Industry Concentration Risk    
Concentration Risk [Line Items]    
% of Portfolio 60.00% 73.00%
Total | Investments at Fair Value | Industry Concentration Risk    
Concentration Risk [Line Items]    
% of Portfolio 100.00% 100.00%
[1] See Note 6 for a discussion of the tax cost of the portfolio.
[2] See Note 6 for a discussion of the tax cost of the portfolio.
[3] Fair value is determined by the Company’s Board of Directors (see Note 2).
[4] Fair value is determined by the Company’s Board of Directors (see Note 2).